Genticel Announces 2015 Annual Results and Strategic Update for 2016
Mar 14, 2016 13:21 pm UTC| Business
Cash position of € 21.8 million as at December 31, 2015First income from partnership with Serum Institute of India Ltd recorded in 2015Operating expenses in line with 2015 clinical milestonesStrategic focus on GTL001...
Mar 14, 2016 13:20 pm UTC| Business
FREMONT, Calif., March 14, 2016 -- Electronics For Imaging, Inc. (Nasdaq:EFII) continues its long-term partnership with Canon by bringing to marketa new Fiery® digital front end for Canon’s new imageRUNNER ADVANCE...
Repros Therapeutics Inc.® Reports Fourth Quarter and Year End 2015 Financial Results
Mar 14, 2016 13:15 pm UTC| Business
THE WOODLANDS, Texas, March 14, 2016 -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced financial results for the fourth quarter and year ended December 31, 2015. Financial Results Net loss for the three...
Navient announces increase and extension of FFELP ABCP facility
Mar 14, 2016 13:11 pm UTC| Business
WILMINGTON, Del., March 14, 2016 -- Navient (Nasdaq:NAVI), the nation’s leading loan management, servicing and asset recovery company, today announced that it has increased and extended its FFELP Asset-Backed Commercial...
Alarm.com and ADT Australia Announce the Introduction of ADT Interactive Security in Australia
Mar 14, 2016 13:10 pm UTC| Business
TYSONS, Va. and SYDNEY, Australia, March 14, 2016 -- Alarm.com (Nasdaq:ALRM), the leading platform for smart home and connected security technology, and ADT Australia, the world’s leader in security solutions, today...
Mar 14, 2016 13:09 pm UTC| Business
NEW YORK, March 14, 2016 -- Greystone Development, a New York-based real estate development, lending and advisory company, announced it has closed on the $23 million acquisition of a development site at 24-16 Queens...
Advaxis to Present at Barclays Global Healthcare Conference
Mar 14, 2016 13:05 pm UTC| Business
PRINCETON, N.J., March 14, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that it is scheduled to present on Wednesday, March 16, 2016 at...